Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Acetic acid + hydrocortisone is a combination otic solution used for the treatment of superficial infections of the external auditory canal. It consists of **acetic acid (2%)**, which provides antibacterial and antifungal activity by lowering the pH of the ear canal environment to inhibit microbial growth, and **hydrocortisone (1%)**, a low-potency corticosteroid that reduces inflammation, edema, and pruritus. This combination is particularly effective for treating acute otitis externa, commonly known as swimmer's ear, in patients aged 3 years and older. The formulation is administered topically into the ear canal and is generally contraindicated in patients with a perforated eardrum.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on acetic acid + hydrocortisone.